In this podcast, Anthony Fauci, MD, from the NIAID, discusses comorbidities in people with HIV and how managing those comorbidities may be hindering progress toward ending the HIV epidemic.
Robin K. Avery, MD, writes about the 7 clinical trials in viral diseases that may change the way cytomegalovirus infection is treated in transplant recipients and how immunizations affect immunocompromised...
In this podcast, Ralph Baric, PhD, from the University of North Carolina at Chapel Hill, discusses his latest research on the National Institute of Health's dengue vaccine, what the findings mean for...
Drs Carlos Arango and Jennifer Andrews from the University of Florida reflect on a 1961 Consultant article about when to prescribe antibiotics to children.
He talks about the recent advancements in the distribution of cells in human tissues that primarily mediate the abnormalities in cystic fibrosis, how these advancements have influenced treatment...
He discusses the need for rapid, efficient development of vaccines for emerging infectious diseases, the 3-prong approach for staying ahead of the curve, and more.
Findings from a new study highlight the gaps in the UNAIDS 90-90-90 targets that are not being bridged. Lead author James Stannah, MPH, answers our questions about his study and how the target can be...
